The company’s Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.
MedVector
Beyond Clinical Trial Sites
The company’s Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.